Adigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d... 25/11/2025 Healthcare Industrial biotechnology Financing The aim of this document is to promote a specific regulatory framework that recognises these technologies as a strategic... AseBio
Adigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d... 25/11/2025 The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities... AseBio
ORYZON reports financial results and corporate update for quarter ended September 30, 2025 11/11/2025 Healthcare Financing The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a... Partners - Oryzon Genomics
AseBio participates in the public consultation of the upcoming Biotech Act with proposals ... 07/11/2025 Healthcare Industrial biotechnology International Financing Harmonizing regulation, improving access to funding and talent, advancing biomanufacturing and artificial intelligence... AseBio
Qida raises €37 million to continue improving the quality of life of the senior segment at... 04/11/2025 Financing The investment will enable Qida to boost growth, technological innovation, and the attraction of top talent, with the... Partners - Asabys Partners
GENESIS Biomed participated in the strategic development of AptaTargets, which has license... 30/10/2025 Access to innovation Financing AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global... Partners - GENESIS Biomed
Oryzon Genomics has strengthened its patent portfolio with the European grant of protectio... 01/10/2025 Financing Oryzon Genomics has strengthened its patent portfolio with the European grant of protection for iadademstat in... Partners - Oryzon Genomics
Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financin... 10/09/2025 Healthcare Access to innovation Financing Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational... Partners - Asabys Partners
CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X ... 09/09/2025 Healthcare Access to innovation Financing CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability data Partners - CONNECTA THERAPEUTICS
Integra Therapeutics secures €10.7 million investment round to advance development of FiCA... 08/09/2025 Healthcare Advanced therapies Financing The investment combines funds from new investors like the EIC Fund (European Commission) and CDTI Innvierte (Government... Partners - Integra Therapeutics S.L.
